DNA X, Inc.
SONM
$4.75
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 16.21M | 11.19M | 16.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 16.21M | 11.19M | 16.72M |
| Cost of Revenue | -- | -- | 14.40M | 10.35M | -- |
| Gross Profit | -- | -- | 1.82M | 845.00K | -- |
| SG&A Expenses | 3.62M | -7.75M | 5.62M | 6.67M | 870.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.62M | -33.58M | 20.19M | 17.92M | 870.00K |
| Operating Income | -3.62M | 6.18M | -3.98M | -6.73M | -870.00K |
| Income Before Tax | -3.93M | 5.01M | -4.66M | -7.34M | -961.00K |
| Income Tax Expenses | -- | -- | 90.00K | 139.00K | -- |
| Earnings from Continuing Operations | -3.93M | 5.23M | -4.75M | -7.48M | -961.00K |
| Earnings from Discontinued Operations | 10.27M | -14.12M | -- | -- | 1.42M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.34M | -8.89M | -4.75M | -7.48M | 458.00K |
| EBIT | -3.62M | 6.18M | -3.98M | -6.73M | -870.00K |
| EBITDA | -2.54M | 7.67M | -3.03M | -5.94M | 185.00K |
| EPS Basic | 5.01 | -9.37 | -4.83 | -14.15 | 1.41 |
| Normalized Basic EPS | -1.94 | 6.39 | -2.96 | -7.97 | -1.85 |
| EPS Diluted | 5.01 | -9.30 | -4.83 | -14.22 | 1.41 |
| Normalized Diluted EPS | -1.94 | 6.39 | -2.96 | -7.97 | -1.85 |
| Average Basic Shares Outstanding | 1.27M | 722.70K | 984.90K | 528.40K | 324.40K |
| Average Diluted Shares Outstanding | 1.27M | 722.70K | 984.90K | 528.40K | 324.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |